Munder Capital Management’s Boston Scientific BSX Stock Holding History

Munder Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	$4.06M	Sell	343,875 -20,805	-6%	-$262K	0.03%	321
2014 Q2	$4.66M	Sell	364,680 -21,921	-6%	-$285K	0.03%	304
2014 Q1	$5.23M	Sell	386,601 -24,120	-6%	-$317K	0.04%	301
2013 Q4	$4.94M	Sell	410,721 -9,211	-2%	-$109K	0.04%	302
2013 Q3	$4.93M	Sell	419,932 -106,981	-20%	-$1.16M	0.04%	294
2013 Q2	$4.88M	Buy	+526,913	New	+$4.47M	0.04%	291

Other funds holding BSX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Munder Capital Management's BSX Position: Q3 2014 in Review

Munder Capital Management reduced its Boston Scientific (BSX) stake by 5.7% in Q3 2014, selling an estimated $262K and leaving 343,875 shares worth $4.06M. The position accounts for 0.03% of the portfolio, ranked #321.

Munder Capital Management first reported a position in BSX in Q2 2013 and has held it in 6 quarters since. The position peaked at $5.23M in Q1 2014. 437 funds tracked by Wall St. Rank hold BSX as of Q3 2014.

Munder Capital Management held 343,875 shares of Boston Scientific worth $4.06M as of Q3 2014.
Munder Capital Management sold 20,805 Boston Scientific shares in Q3 2014, an estimated $262K.
Boston Scientific made up 0.03% of Munder Capital Management's portfolio in Q3 2014, its #321 holding.
Munder Capital Management first reported a position in Boston Scientific in Q2 2013 and has held it in 6 quarters since.
Munder Capital Management's Boston Scientific position peaked at $5.23M in Q1 2014.
437 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2014.

Based on Munder Capital Management's 13F filing for Q3 2014, filed 31 Oct 2014.